Success in clinical trials
Shift in the treatment of blood cancers taking place.
Showing 121 - 140 of 271 results
Shift in the treatment of blood cancers taking place.
ANSTO expertise provides much-needed information about groundwater resources in the Mozambique capital and district.
ANSTO has almost seventy years of experience in advancing an understanding of the management of spent nuclear fuel and delivering safe and reliable forms for radioactive waste.
The Medium Energy- X-ray Absorption Spectroscopy beamlines will provide access to XANES and EXAFS data from a bending magnet source, optimised for cutting-edge applications in biological, agricultural and environmental science in an energy range that is not currently available at the Australia Synchrotron.
ANSTO Big Ideas encourages students to creatively communicate the work of an Australian scientist, and explain how their work has inspired them to come up with a Big Idea to make our world a better place. This competition is intended to engage and support Australian students in years 7-10 in Science and encourage them to pursue studies and careers in STEM.
The independent nuclear regulator, ARPANSA, is currently accepting submissions about ANSTO’s planned $59.8 million Intermediate Level Solid Waste Storage Facility.
In accordance with the Trust Deed, the United Uranium Scholarship is awarded to ‘promising young scientists’ from any Australian organisation or institution whose research or work is in the field of nuclear energy.
The SAAFE Program supports early career researchers at PhD and Postdoctoral level to expand research and innovation activities within Human Health, the Environment and the Nuclear Fuel Cycle, to initiate sustainable research networks and linkages to support Australia, New Zealand and France research and innovation.
Research to characterise how radioactive contaminants impact the surrounding environment.
The Advanced Diffraction and Scattering beamlines (ADS-1 and ADS-2) are two independently operating, experimentally flexible beamlines that will use high-energy X-ray diffraction and imaging to characterise the structures of new materials and minerals.
Cyclotek and ANSTO have announced the launch of a Joint Venture (JV), to establish Australia’s first GMP (Good Manufacturing Practice) theranostics facility starting in Melbourne, Australia.
The need for a smaller, more transportable version of ANSTO’s 1500-litre atmospheric radon-222 monitor, and with a calibration traceable to the International System of Units, prompted the team to develop a 200-litre radon monitor that would meet those needs.
A new nuclear medicine waste processing facility that showcases ANSTO Synroc technology is under construction.
Commitment to undertake health research.